Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cochlear Limited
  6. Summary
    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/11/2022 01/12/2022 01/13/2022 01/14/2022 01/17/2022 Date
206.02(c) 207.73(c) 205.26(c) 201.1(c) 204.11(c) Last
110 730 102 157 77 029 116 202 150 871 Volume
-0.71% +0.83% -1.19% -2.03% +1.50% Change
More quotes
Estimated financial data (e)
Sales 2022 1 659 M 1 195 M 1 195 M
Net income 2022 277 M 200 M 200 M
Net cash position 2022 566 M 408 M 408 M
P/E ratio 2022 47,9x
Yield 2022 1,50%
Sales 2023 1 840 M 1 326 M 1 326 M
Net income 2023 321 M 231 M 231 M
Net cash position 2023 626 M 451 M 451 M
P/E ratio 2023 41,4x
Yield 2023 1,77%
Capitalization 13 425 M 9 700 M 9 671 M
EV / Sales 2022 7,75x
EV / Sales 2023 6,95x
Nbr of Employees 4 000
Free-Float -
More Financials
Company
Cochlear Limited is an Australian-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three geographical segments: Americas, EMEA and Asia Pacific. Its products offer various ways to hear, such as automatically adjusting hearing to different environments and streaming sound from a smartphone. It... 
More about the company
Ratings of Cochlear Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about COCHLEAR LIMITED
01/11FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafnes..
CI
01/05Tech, healthcare pull down Australian shares from mid-Aug highs
RE
2021Healthcare, mining stocks help Australian shares notch best day in 2 weeks
RE
2021Cochlear Limited Announces Appointment of Michael Del Prado to Board
CI
2021COCHLEAR : 2021 Modern Slavery Statement
PU
2021Cochlear North America Announces Management Changes
CI
2021COCHLEAR : reinforces commitment to reconciliation with launch of Reconciliation Action Pl..
PU
2021DEMANT A/S : Halts Sales for Cochlear Implants Amid Performance Issues
MT
2021Cochlear Limited Announces FDA Approval and FDA Clearance of First-Of-Its-Kind Remote C..
CI
2021PRECISIS AG announced that it has received €20 million in funding from Cochlear Li..
CI
2021COCHLEAR : Faces Patent Infringement Complaint in US
MT
2021COCHLEAR LIMITED : Ex-dividend day for final dividend
FA
2021COCHLEAR : Foundation launches global partnership with Malala Fund to remove hearing loss ..
PU
2021SENSORION : Cochlear to Start Pilot Study of Hearing Preservation Drug
MT
2021Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservati..
CI
More news
News in other languages on COCHLEAR LIMITED
01/11La FDA approuve les implants du noyau cochléaire pour les pertes auditives unilatérales..
2021Sonova-Aktien leiden unter Gewinnmitnahmen nach Zahlen zum Halbjahr
2021MÄRKTE ASIEN/Börsen mit Aufschlägen - Sydney bleibt zurück
2021Demant interrompt les ventes d'implants cochléaires en raison de problèmes de performan..
2021Apple prüft das Potenzial der AirPods als Gesundheitsgerät
More news
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 201,10 AUD
Average target price 220,68 AUD
Spread / Average Target 9,74%
EPS Revisions
Managers and Directors
Diggory William Howitt President, CEO, Executive Director & MD
Stuart Sayers Chief Financial Officer & President-Services
Catriona Alison Deans Chairman
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COCHLEAR LIMITED-6.95%9 557
STRAUMANN HOLDING AG-14.77%28 769
SONOVA HOLDING AG-10.17%21 939
DEMANT A/S-8.03%11 321
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-3.42%3 360
ÖSSUR HF.0.24%2 748